Applied Clinical Trials-11-01-2021

Meeting patients at the point of care can increase trust and engagement.

Proactive, pervasive, and strategic planning lead industry into future.

Four industry executives share insights during the Media and Analyst Roundtable at Veeva's R&D and Quality Summit Connect.

In this interview, Dave Hanaman, co-founder, president and chief commercial operator at Curavit Clinical Research discusses launching the organization at the start of the pandemic and how it operates with a commitment to designing trials with a fully virtual site.

Improvement is needed in clarifying the therapeutic development process.

Click the title above for a link to open the Applied Clinical Trials November 2021 issue in an interactive PDF format.

European authorities have announced a proposal for a framework to support not-for-profit organizations and academia in repurposing authorized medicines.

Elderly patients achieved up to 98% compliance at 18 months on Phase III study.

FDA seeks to address the hurdles for incorporating real world data into submissions, while addressing concerns about relevance and reliability.

Cloud-based clinical metadata repositories can aid in accelerating clinops.

Lessons learned during the pandemic from University of Louisville.